Literature DB >> 31479642

Gender Differences in Outcomes After Implantation of Left Ventricular Assist Devices.

Abdelrahman Ahmed1, Oluwole Adegbala2, Emmanuel Akintoye3, Chakradhari Inampudi3, Mustafa Ajam1, Ahmed S Yassin1, Emmanuel Olawusi1, Mohamed Shokr1, Paulino Alvarez3, Alexandros Briasoulis4.   

Abstract

BACKGROUND: Left ventricular assist device (LVAD) implantation has historically been underutilized in women compared with men. It was hypothesized that the introduction of continuous-flow LVADs would lead to more LVAD implantations in women and possibly narrow the gender gap.
METHODS: Patients who underwent LVAD implantation between 2009 and 2014 were identified using the national inpatient sample.
RESULTS: A total of 3511 patients (17,251 when weighted) underwent LVAD implantation in the United States between 2009 and 2014. Mean age was 56 years and there were 817 women in the study sample (23.32%). LVAD implantations in women doubled from 2009 to 2014, but men continued to receive LVAD 3 times more than women. Inpatient mortality after LVAD placement was similar between men and women (13.42% women vs 12.85% men; odds ratio, 1.05; P = .16). Most common complications after LVAD implantation in both genders included acute kidney injury, bleeding requiring blood transfusion, and postoperative sepsis. There were no gender-specific differences in the incidence of periprocedural complications, including postoperative cardiac tamponade, postoperative thromboembolism, or sepsis. In addition, no significant difference was found in length of stay and median hospitalization cost. The use of extracorporeal membrane oxygenation did not differ between men and women. Subgroup analysis in patients older than 65 years of age showed higher in-hospital mortality but no differences between genders.
CONCLUSIONS: The number of women undergoing LVAD implantation has increased with the introduction of continuous-flow LVADs, but a gender gap still exists. Most major in-hospital outcomes after LVAD implantation are similar between genders.
Copyright © 2020 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2019        PMID: 31479642     DOI: 10.1016/j.athoracsur.2019.07.032

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  9 in total

1.  Sex differences in outcomes following less-invasive left ventricular assist device implantation.

Authors:  Silvia Mariani; Tong Li; Karl Bounader; Dietmar Boethig; Alexandra Schöde; Jasmin S Hanke; Jana Michaelis; L Christian Napp; Dominik Berliner; Guenes Dogan; Roberto Lorusso; Axel Haverich; Jan D Schmitto
Journal:  Ann Cardiothorac Surg       Date:  2021-03

2.  Influence of Gender in Advanced Heart Failure Therapies and Outcome Following Transplantation.

Authors:  María Dolores García-Cosío; Francisco González-Vilchez; Raquel López-Vilella; Eduardo Barge-Caballero; Manuel Gómez Bueno; Manuel Martínez-Selles; Jose María Arizón; Diego Rangel Sousa; José González-Costello; Sonia Mirabet; Félix Pérez-Villa; Beatriz Díaz Molina; Gregorio Rábago; Ana Portolés Ocampo; Luis de la Fuente Galán; Iris Garrido; Juan F Delgado
Journal:  Front Cardiovasc Med       Date:  2021-02-25

3.  Incidence and impact of acute kidney injury on patients with implantable left ventricular assist devices: a Meta-analysis.

Authors:  Charat Thongprayoon; Ploypin Lertjitbanjong; Wisit Cheungpasitporn; Panupong Hansrivijit; Tibor Fülöp; Karthik Kovvuru; Swetha R Kanduri; Paul W Davis; Saraschandra Vallabhajosyula; Tarun Bathini; Kanramon Watthanasuntorn; Narut Prasitlumkum; Ronpichai Chokesuwattanaskul; Supawat Ratanapo; Michael A Mao; Kianoush Kashani
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

4.  Complications of left ventricular assist devices causing high urgency status on waiting list: impact on outcome after heart transplantation.

Authors:  Moritz Benjamin Immohr; Udo Boeken; Franziska Mueller; Emir Prashovikj; Michiel Morshuis; Charlotte Böttger; Hug Aubin; Jan Gummert; Payam Akhyari; Artur Lichtenberg; René Schramm
Journal:  ESC Heart Fail       Date:  2021-01-21

5.  Sex Differences in Recovery and Device Replacement After Left Ventricular Assist Device Implantation as Destination Therapy.

Authors:  Lisa-Marie Maukel; Gerdi Weidner; Jan Beyersmann; Heike Spaderna
Journal:  J Am Heart Assoc       Date:  2022-02-22       Impact factor: 6.106

Review 6.  Special Considerations in the Care of Women With Advanced Heart Failure.

Authors:  Imo A Ebong; Ersilia M DeFilippis; Eman A Hamad; Eileen M Hsich; Varinder K Randhawa; Filio Billia; Mahwash Kassi; Anju Bhardwaj; Mirnela Byku; Mrudala R Munagala; Roopa A Rao; Amy E Hackmann; Claudia G Gidea; Teresa DeMarco; Shelley A Hall
Journal:  Front Cardiovasc Med       Date:  2022-07-11

7.  Racial and Sex Inequities in the Use of and Outcomes After Left Ventricular Assist Device Implantation Among Medicare Beneficiaries.

Authors:  Thomas M Cascino; Sriram Somanchi; Monica Colvin; Grace S Chung; Alexander A Brescia; Michael Pienta; Michael P Thompson; James W Stewart; Devraj Sukul; Daphne C Watkins; Francis D Pagani; Donald S Likosky; Keith D Aaronson; Jeffrey S McCullough
Journal:  JAMA Netw Open       Date:  2022-07-01

8.  Inpatient Specialist Palliative Care in Patients With Left Ventricular Assist Devices (LVAD): A Retrospective Case Series.

Authors:  Theresa Tenge; David Santer; Daniel Schlieper; Manuela Schallenburger; Jacqueline Schwartz; Stefan Meier; Payam Akhyari; Otmar Pfister; Silke Walter; Sandra Eckstein; Friedrich Eckstein; Martin Siegemund; Jan Gaertner; Martin Neukirchen
Journal:  Front Cardiovasc Med       Date:  2022-06-29

9.  Impact of gender in patients with continuous-flow left ventricular assist device therapy in end-stage heart failure.

Authors:  Alina Zubarevich; Marcin Szczechowicz; Anja Osswald; Arian Arjomandi Rad; Robert Vardanyan; Michel Pompeu Bo Sá; Jef Van den Eynde; Bastian Schmack; Daniel Wendt; Achim Koch; Nikolaus Pizanis; Markus Kamler; Arjang Ruhparwar; Alexander Weymann; Konstantin Zhigalov
Journal:  Int J Artif Organs       Date:  2021-03-30       Impact factor: 1.595

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.